Items by Bailey, Sarah
 | Up a level |
Number of items: 43.
Book Sections
Bailey, S. J. and McCaffery, P. J., 2010. Vulnerability of the brain to neuropsychiatric disorders resulting from abnormal thyroid hormone or vitamin D homeostasis. In: Ritsner, M., ed. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Netherlands: Springer, pp. 105-133.
Bailey, S. J. and McCaffery, P. J., 2009. Retinoic acid signalling in neuropsychiatric disease: possible markers and treatment agents. In: Ritsner, M. S., ed. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes, and Genes. Volume III: Metabolic and Peripheral Biomarkers.Vol. 3. Netherlands: Springer, pp. 171-189.
Articles
Bailey, S., 2015. A Single Compound Alternative to a Buprenorphine/Naltrexone Combination, a functional kappa opioid receptor antagonist, produces antidepressant-like effects in mice. Journal of Psychopharmacology, 29 (8 (Abstract Suppleme), A22.
Sadler, A. and Bailey, S., 2015. Chronic restraint stress increases depression-related behaviour in the sucrose preference test in juvenile and adult mice. Journal of Psychopharmacology, 29 (8 (Abstract Suppleme), A02.
Wickens, R., Ver Donck, L., Mackenzie, A. and Bailey, S., 2015. The effect of housing conditions on lipopolysaccharide-induced depressive-like behaviour in mice. Journal of Psychopharmacology, 29 (8 (Abstract Suppleme), A08.
Almatroudi, A., Husbands, S. M., Bailey, C. P. and Bailey, S. J., 2015. Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice. Journal of Psychopharmacology, 29 (7), pp. 812-821.
Wickens, R., Ver Donck, L., Mackenzie, A. and Bailey, S. J., 2014. Acute And Chronic Lipopolysaccharide Induces Sickness But Fails To Produce A Depressive-Like Behaviour In Mice. Journal of Psychopharmacology, 28 (8), A107.
Almatroudi, A., Husbands, S. M., Bailey, C. P. and Bailey, S. J., 2014. Combination Treatment With Buprenorphine/Naltrexone, A Functional Kappa Opioid Receptor Antagonist, Produces Antidepressant-Like Effects In Mice. Journal of Psychopharmacology, 28 (8), A101.
Sadler, A. and Bailey, S. J., 2014. Evaluating gender differences in behaviour in the elevated plus maze in cd-1 and C57BL/6 mice. Journal of Psychopharmacology, 28 (8), A59.
Sadler, A. and Bailey, S. J., 2014. The effect of chronic restraint stress on depression-related behaviour in juvenile and adult C57BL/6 mice. Journal of Psychopharmacology, 28 (8), A103.
Casal-Dominguez, J. J., Furkert, D., Ostovar, M., Teintang, L., Clarke, M. J., Traynor, J. R., Husbands, S. M. and Bailey, S. J., 2014. Characterization of BU09059:A novel potent selective κ-receptor antagonist. ACS Chemical Neuroscience, 5 (3), pp. 177-184.
Sadler, A. M. and Bailey, S. J., 2013. Validation of a refined technique for taking repeated blood samples from juvenile and adult mice. Laboratory Animals, 47 (4), pp. 316-319.
Casal-Dominguez, J. J., Clark, M., Traynor, J. R., Husbands, S. M. and Bailey, S. J., 2013. In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor. Journal of Psychopharmacology, 27 (2), pp. 192-202.
Almatroudi, A., Husbands, S. M., Bailey, C. P. and Bailey, S. J., 2013. Establishing the combination of buprenorphine and naltrexone as a functional kappa opioid receptor antagonist in mice. Proceedings of the British Pharmacological Society
Wickens, R. A., Ver Donck, L., Bailey, S. J. and Mackenzie, A. B., 2013. Lipopolysaccharide regulation of the NLRP3 inflammasome and proIL-1β under normoxic versus hypoxic conditions in cultured (BV-2) mouse microglia. Proceedings of the British Pharmacological Society, 11 (3).
Sadler, A. and Bailey, S., 2013. The effect of chronic restraint stress on anxiety-related behaviour in the elevated plus maze. Journal of Psychopharmacology, 27 (8), A17.
Bailey, S., Casal-Dominguez, J. and Husbands, S. M., 2012. Antidepressant effects of novel kappa-opioid receptor antagonists in the forced swim test. Journal of Psychopharmacology, 26 (8), A16.
Drew, C. J. G., O'Reilly, K. C., Lane, M. A. and Bailey, S. J., 2011. Chronic administration of 13-cis-retinoic acid does not alter the number of serotoninergic neurons in the mouse raphe nuclei. Neuroscience, 172, pp. 66-73.
Bailey, S. J., Casal-Dominguez, J. J. and Husbands, S. M., 2011. Anxiolytic effects of novel kappa-opioid receptor antagonists in the elevated plus maze. Journal of Psychopharmacology, 25 (8), A76.
Bailey, S. J., Casal-Dominguez, J. J., Bradbury, F. A., Traynor, J. R. and Husbands, S. M., 2010. In vivo characterisation of 5'-amino and amidino-alkyl,naltrindole derivatives at the kappa-opioid receptor. Journal of Psychopharmacology, 24 (Supplement 3), A42.
Trent, S., Drew, C. J. G., Mitchell, P. J. and Bailey, S. J., 2009. Chronic treatment with 13-cis-retinoic acid changes aggressive behaviours in the resident-intruder paradigm in rats. European Neuropsychopharmacology, 19 (12), pp. 876-886.
O'Reilly, K. C., Shumake, J., Bailey, S. J., Gonzalez-Lima, F. and Lane, M. A., 2009. Chronic 13-cis-retinoic acid administration disrupts network interactions between the raphe nuclei and the hippocampal system in young adult mice. European Journal of Pharmacology, 605 (1-3), pp. 68-77.
O'Reilly, K., Bailey, S. J. and Lane, M. A., 2008. Retinoid-mediated regulation of mood: Possible cellular mechanisms. Experimental Biology and Medicine, 233 (3), pp. 251-258.
O'Reilly, K. C., Bailey, S. J. and Lane, M. A., 2007. 13-Cis-retinoic acid alters serotonin reuptake transporter levels in RN46A-B14 raphe nuclei cells. FASEB Journal, 21 (6), A1178-A1178.
O'Reilly, K. C., Trent, S., Bailey, S. J. and Lane, M. A., 2007. 13-cis-retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro. Experimental Biology and Medicine, 232, pp. 1195-1203.
Bailey, S. J., Ravier, M. A. and Rutter, G. A., 2007. Glucose-dependent regulation of γ-Aminobutyric Acid (GABAA) receptor expression in mouse pancreatic islet α-cells. Diabetes, 56 (2), pp. 320-327.
Mountjoy, P. D., Bailey, S. J. and Rutter, G. A., 2007. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity. Diabetologia, 50, pp. 168-177.
O'Reilly, K. C., Shumake, J., Gonzalez-Lima, F., Lane, M. A. and Bailey, S. J., 2006. Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychopharmacology, 31 (9), pp. 1919-1927.
Slater, C. R., Fawcett, P. R. W., Walls, T. J., Lyons, P. R., Bailey, S. J., Beeson, D., Young, C. and Gardner-Medwin, D., 2006. Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'. Brain, 129, pp. 2061-2076.
Woodhall, G. L., Bailey, S. J., Thompson, S. E., Evans, D. I. P. and Jones, R. S. G., 2005. Fundamental differences in spontaneous synaptic inhibition between deep and superficial layers of the rat entorhinal cortex. Hippocampus, 15 (2), pp. 232-245.
Lane, M. A. and Bailey, S. J., 2005. Role of retinoid signalling in the adult brain. Progress in Neurobiology, 75, pp. 275-293.
Bailey, S. J., Dhillon, A., Woodhall, G. L. and Jones, R. S. G., 2004. Lamina-specific differences in GABAB autoreceptor-mediated regulation of spontaneous GABA release in rat entorhinal cortex. Neuropharmacology, 46, pp. 31-42.
Bailey, S. J. and Toth, M., 2004. Variability in the benzodiazepine response of serotonin 5-HT 1A receptor null mice displaying anxiety-lie phenotype: evidence for genetic modifiers in the 5-HT-mediated regulation of GABA A receptors. Journal of Neuroscience, 24 (28), pp. 6343-6351.
Bailey, S. J., Stocksley, M. A., Buckel, A., Young, C. and Slater, C. R., 2003. Voltage-gated sodium channels and ankyrinG occupy a different postsynaptic domain from acetylcholine receptors from an early stage of neuromuscular junction maturation in rats. Journal of Neuroscience, 23 (6), pp. 2102-2111.
Wood, S. J. and Toth, M., 2001. Molecular pathways of anxiety revealed by knockout mice. Molecular Neurobiology, 23 (2-3), pp. 101-119.
Wood, S. and Slater, C. R., 2001. Safety factor at the neuromuscular junction. Progress in Neurobiology, 64 (4), pp. 393-429.
Olivier, B., Pattij, T., Wood, S. J., Oosting, R., Sarnyai, Z. and Toth, M., 2001. The 5-HT1A receptor knockout mouse and anxiety. Behavioural Pharmacology, 12 (6-7), pp. 439-450.
Conference or Workshop Items
Bailey, S., Cadman, L., Stevens, E., Laughton, F. and Shermer, D., 2015. Bringing public engagement into the undergraduate pharmacology curriculum:a cross-departmental initiative. In: Pharmacology 2015, 2015-12-15 - 2015-12-17.
Wickens, R., Ver Donck, L., Bailey, S. and Mackenzie, A., 2015. Primary microglia isolated from neonatal mice provide a model for the study of NLRP3 inflammasome and the effect of long-term hypoxia. In: Society for Neuroscience 2015, 2015-10-17 - 2015-10-21, Chicago.
Bailey, S., Almatroudi, A. M. I., Bailey, C. and Husbands, S., 2015. The antidepressant-like effects of BU10119, a novel kappa opioid receptor antagonist, in the novelty-induced hypophagia task in mice. In: Society for Neuroscience 2015, 2015-10-17 - 2015-10-21, Chicago.
Sadler, A. and Bailey, S., 2014. Differential gene expression of components of the hypothalamic-pituitary adrenal axis signalling in juvenile and adult mice. In: Society for Neuroscience, 2014-11-15.
Bailey, S., Almatroudi, A. M. I., Bailey, C. and Husbands, S., 2014. The antidepressant-like effects of combination buprenorphine/naltrexone in the novelty-induced hypophagia task in mice. In: Society for Neuroscience, 2014-11-15.
